ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA-Salt Rats

Hypertension

Volumn 43, Issue 4, 2004, Pages 872-879

  Callera, Glaucia E ^a,b   Montezano, Augusto C ^a   Touyz, Rhian M ^b   Zorn, Telma M T ^a   Carvalho, Maria Helena C ^a   Fortes, Zuleica B ^a   Nigro, Dorothy ^a   Schiffrin, Ernesto L ^b   Tostes, Rita C A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Arterial; Cell adhesion molecules; Deoxycorticosterone; Endothelin; Hypertension; Leukocytes

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CELL ADHESION MOLECULE; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; PADGEM PROTEIN; SODIUM CHLORIDE; VASCULAR CELL ADHESION MOLECULE 1; 5 (DIMETHYLAMINO) N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; 5-(DIMETHYLAMINO)-N-(3,4-DIMETHYL-5-ISOXAZOLYL)-1-NAPHTHALENESULFONAMIDE; DANSYL CHLORIDE; DEOXYCORTICOSTERONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL INTERACTION; CONTROLLED STUDY; DEOXYCORTICOSTERONE SALT RAT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FASCIA; GENE EXPRESSION REGULATION; HEART INJURY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERNAL SPERMATIC FASCIA; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MACROPHAGE; MALE; MICROSCOPY; MINERALOCORTICOID HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENULE; VITAL STAIN; ANIMAL; BIOSYNTHESIS; CELL ADHESION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; HEART MUSCLE; METABOLISM; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; SALT INTAKE; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CHEMOTAXIS, LEUKOCYTE; DANSYL COMPOUNDS; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HYPERTENSION; HYPERTENSION, RENOVASCULAR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MACROPHAGES; MALE; MYOCARDIUM; NEPHRECTOMY; P-SELECTIN; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM CHLORIDE, DIETARY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1642460606     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000117296.30296.14     Document Type: Article

References (45)

1. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
2. Barton M, d'Uscio LV, Shaw S, Meyer P, Moreau P, Luscher TF. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension. 1998;31:499-504.
3. Rothermund L, Yagil Y, Yagil C, Traupe T, Neumayer HH, Paul M, Kreutz R. Selective ETA-receptor antagonism attenuates the hypertensive response to salt and target organ damage in the Sabra experimental model of salt-sensitive genetic hypertension. J Am Soc Nephrol. 1999;10:1789.
4. Park JB, Schiffrin EL. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens. 2002;15:164-169.
5. Schiffrin EL, Deng LY, Sventek P, Day R. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens. 1997;15:57-63.
6. Müller DN, Mervaala EMA, Schmidt F, Park JK, Dechend R, Genersch E, Breu B, Löffler BM, Ganten D, Schneider W, Haller, Luft FC. Effect of bosentan on NF-kB, inflammation, and tissue factor on angiotensin II-induced end-organ damage. Hypertension. 2000;36:282-290.
7. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens. 2003;2:181-187.
8. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens. 2001;14:44S-54S.
9. Mervaala EM, Muller DN, Park JK, Schmidt F, Lohn M, Breu V, Dragun D, Ganten D, Haller H, Luft FC. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension. 1999;33:389-395.
10. Haller H, Park JK, Dragun D. Lippoldt A, Luft FC. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transpl. 1997;12:899-903.
11. Mai M, Hilgers KF, Geiger H. Experimental studies on the role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in hypertensive nephrosclerosis. Hypertension. 1996;28:973-979.
12. Komatsu S, Panes J, Russell JM, Anderson DC, Muzykantov VR, Miyasaka M, Granger DN. Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecules-1 expression in vivo. Hypertension. 1997;29:683-689.
13. Tostes RC, Touyz RM, He G, Chen X, Schiffrin EL. Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension. Clin Sci. 2002;103:25S-30S.
14. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
15. Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL. Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension. 2002;39:679-684.
16. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38:1107-1111.
17. Iglarz M, Touyz RM, Amiri F, Lavoie M-F, Diep QN, Schiffrin EL. Effect of peroxisome proliferator-activated receptor-alpha and receptor-gamma activators on vascular remodeling in endothelin-dependent hypertension. Arterioscl Thromb Vasc Biol. 2003;23:45-51.
18. A receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension. 2003;42[part 2]:811-817.
19. B receptor-mediated vascular responses. Br J Pharmacol. 2000;130:1092-1098.
20. Cruz JW, Oliveira MA, Hohman TC, Fortes ZB. Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes. Eur J Pharmacol. 2000;391:163-174.
21. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme, J. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes. 1991;40:1267-1273.
22. Vestweber D. Regulation of endothelial cell contacts during leukocyte extravasation. Curr Opin Cell Biol. 2002;14:587-593.
23. Eriksson EE, Werr J, Guo Y, Thoren P, Lindbom L. Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta. Circ Res. 2000;86:526-533.
24. Tiefenbacher CP, Kapitza J, Dietz V, Lee CH, Niroomand F. Reduction of myocardial infarct size by fluvastatin. Am J Physiol. 2003;285: H59-H64.
25. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581-587.
26. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000;36:312-318.
27. Arndt H, Smith CW, Granger DN. Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats. Hypertension. 1993;21:667-673.
28. Suzuki H, Schmid-Schonbein GW, Suematsu M, DeLano FA, Forrest MJ, Miyasaka M, Zweifach BW. Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension. 1994;24:719-727.
29. Suematsu M, Suzuki H, Tamatani T, Iigou Y, DeLano FA, Miyasaka M, Forrest MJ, Kannagi R, Zweifach BW, Ishimura Y. Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest. 1995;96:2009-2016.
30. Kurose I, Wolf R, Cerwinka W, Granger DN. Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension. 1999;34:212-216.
31. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193-201.
32. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001;37:781-786.
33. Lopez Farre A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Monton M, Rivas F, Gallego MJ, Egido J. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 1993;88:1166-1171.
34. Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM, Pohlman TH. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci USA. 1991;88:6523-6527.
35. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med. 1999;4:223-230.
36. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
37. A-selective endothelin receptor antagonists on blood pressure and small artery structure of DOCA-salt hypertensive rats. Am J Hypertens. 1998;11:554-562.
38. Day R, Larivière R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens. 1995;8:294-300.
39. Ammarguellat F, Larouche II, Schiffrin EL. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation. 2001;103:319-324.
40. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens. 2001;14:83S-89S.
41. Sanz MJ, Johnston B, Issekutz A, Kubes P. Endothelin-1 causes P-selectin-dependent leukocyte rolling and adhesion within rat mesenteric microvessels. Am J Physiol. 1999;277:H1823-H1830.
42. Ishizuka T, Takamizawa-Matsumoto M, Suzuki K, Kurita A. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol. 1999;369:237-245.
43. Luft FC. Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens. 2002;11:59-66.
44. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Munter K, Luscher TF. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 1998;95:14367-14372.
45. Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. J Cardiovasc Pharmacol 1995;26:S5-S8.